Canada Life’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-7,923
| Closed | -$93K | – | 2377 |
|
2022
Q3 | $93K | Buy |
7,923
+7,036
| +793% | +$82.6K | ﹤0.01% | 1999 |
|
2022
Q2 | $10K | Hold |
887
| – | – | ﹤0.01% | 2365 |
|
2022
Q1 | $28K | Hold |
887
| – | – | ﹤0.01% | 2291 |
|
2021
Q4 | $23K | Hold |
887
| – | – | ﹤0.01% | 2348 |
|
2021
Q3 | $32K | Hold |
887
| – | – | ﹤0.01% | 2345 |
|
2021
Q2 | $38K | Hold |
887
| – | – | ﹤0.01% | 2345 |
|
2021
Q1 | $30K | Hold |
887
| – | – | ﹤0.01% | 2445 |
|
2020
Q4 | $31K | Hold |
887
| – | – | ﹤0.01% | 2448 |
|
2020
Q3 | $21K | Hold |
887
| – | – | ﹤0.01% | 2433 |
|
2020
Q2 | $16K | Hold |
887
| – | – | ﹤0.01% | 2530 |
|
2020
Q1 | $14K | Hold |
887
| – | – | ﹤0.01% | 2449 |
|
2019
Q4 | $19K | Buy |
+887
| New | +$19K | ﹤0.01% | 2510 |
|
2019
Q3 | – | Sell |
-1,671
| Closed | -$43K | – | 2024 |
|
2019
Q2 | $43K | Hold |
1,671
| – | – | ﹤0.01% | 2479 |
|
2019
Q1 | $42K | Hold |
1,671
| – | – | ﹤0.01% | 2293 |
|
2018
Q4 | $37K | Hold |
1,671
| – | – | ﹤0.01% | 2459 |
|
2018
Q3 | $54K | Hold |
1,671
| – | – | ﹤0.01% | 2376 |
|
2018
Q2 | $47K | Hold |
1,671
| – | – | ﹤0.01% | 2414 |
|
2018
Q1 | $59K | Hold |
1,671
| – | – | ﹤0.01% | 2329 |
|
2017
Q4 | $65K | Buy |
+1,671
| New | +$65K | ﹤0.01% | 2290 |
|
2014
Q4 | – | Sell |
-445
| Closed | -$9K | – | 2569 |
|
2014
Q3 | $9K | Hold |
445
| – | – | ﹤0.01% | 2403 |
|
2014
Q2 | $16K | Hold |
445
| – | – | ﹤0.01% | 2269 |
|
2014
Q1 | $17K | Hold |
445
| – | – | ﹤0.01% | 2156 |
|
2013
Q4 | $13K | Buy |
+445
| New | +$13K | ﹤0.01% | 2180 |
|